➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

PACERONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Pacerone patents expire, and what generic alternatives are available?

Pacerone is a drug marketed by Upsher Smith Labs and is included in one NDA.

The generic ingredient in PACERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.

Drug patent expirations by year for PACERONE
Drug Prices for PACERONE

See drug prices for PACERONE

Drug Sales Revenue Trends for PACERONE

See drug sales revenues for PACERONE

Recent Clinical Trials for PACERONE

Identify potential brand extensions & 505(b)(2) entrants

The University of Texas Health Science Center at San AntonioPhase 4
National Institute on Drug Abuse (NIDA)Phase 4
Rockefeller UniversityPhase 4

See all PACERONE clinical trials

US Patents and Regulatory Information for PACERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs PACERONE amiodarone hydrochloride TABLET;ORAL 075135-002 Apr 12, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs PACERONE amiodarone hydrochloride TABLET;ORAL 075135-001 Apr 30, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.